Showing 761 - 780 results of 10,612 for search '"real life"', query time: 0.24s Refine Results
  1. 761

    Clinical and economic consequences of ozenoxacin vs. other topical antibiotics for the treatment of impetigo: a real-life study in Spain by Jaime Rodríguez Quintosa, Cintia Cristina Ago, Antoni Sicras Mainar, Renata Villoro, Inés Pérez-Román

    Published 2022-10-01
    “…Methods: This is a retrospective observational study using real-life data from electronic medical records of patients with impetigo who started treatment with OZ, MUP or FA (maximum follow-up: 3 months; n = 10,974). …”
    Get full text
    Article
  2. 762

    Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors and Applicability of First-Line Atezolizumab/Bevacizumab in a Real-Life Setting by Maria Corina Plaz Torres, Quirino Lai, Fabio Piscaglia, Eugenio Caturelli, Giuseppe Cabibbo, Elisabetta Biasini, Filippo Pelizzaro, Fabio Marra, Franco Trevisani, Edoardo G. Giannini

    Published 2021-07-01
    “…For instance, the actual proportion of patients who are deemed eligible for ICIs in the real-life ranges from 10% to 20% in the first-line setting, and is even lower in the second-line scenario. …”
    Get full text
    Article
  3. 763
  4. 764
  5. 765
  6. 766

    Real‐life self‐assessment of pruritus relief with a combination of calcipotriol/betamethasone dipropionate foam in patients with plaque psoriasis by Laurent Misery, Jessica Gonnet, Nadine Mackenzie, Nathalie Beneton, Bruno Halioua

    Published 2022-12-01
    “…Our main objective was to document, in real‐life clinical practice, the perception of pruritus and the efficacy of a 4‐week topical treatment with a fixed‐dose combination of calcipotriol/betamethasone dipropionate (Cal/BD) foam on psoriasis‐related moderate‐to‐severe pruritus. …”
    Get full text
    Article
  7. 767
  8. 768
  9. 769
  10. 770
  11. 771

    Natalizumab treatment reduces fatigue in multiple sclerosis. Results from the TYNERGY trial; a study in the real life setting. by Anders Svenningsson, Eva Falk, Elisabeth G Celius, Siegrid Fuchs, Karen Schreiber, Sara Berkö, Jennifer Sun, Iris-Katharina Penner, Tynergy Trial Investigators

    Published 2013-01-01
    “…All patients were aware of the nature of the treatment agent, and of the study outcomes.Natalizumab, as used in a real-life setting, might improve MS-related fatigue based on the results from this one-armed un-controlled stud. …”
    Get full text
    Article
  12. 772
  13. 773

    Clinical Remission in Patients Affected by Severe Eosinophilic Asthma on Dupilumab Therapy: A Long-Term Real-Life Study by Carla Maria Irene Quarato, Pasquale Tondo, Donato Lacedonia, Piera Soccio, Paolo Fuso, Eugenio Sabato, Anela Hoxhallari, Maria Pia Foschino Barbaro, Giulia Scioscia

    Published 2024-01-01
    “…</b> Nowadays, highly selective biological drugs offer the possibility of treating severe type 2 asthma. However, in the real-life setting, it is crucial to confirm the validity of the chosen biological treatment by evaluating the achievement of clinical remission. …”
    Get full text
    Article
  14. 774
  15. 775
  16. 776

    Adalimumab and ABP 501 in the Treatment of a Large Cohort of Patients with Inflammatory Arthritis: A Real Life Retrospective Analysis by Andrea Becciolini, Simone Parisi, Rosalba Caccavale, Elena Bravi, Federica Lumetti, Romina Andracco, Alessandro Volpe, Lucia Gardelli, Francesco Girelli, Eleonora Di Donato, Daniele Santilli, Gianluca Lucchini, Maria Chiara Ditto, Ilaria Platè, Eugenio Arrigoni, Flavio Mozzani, Michele Riva, Antonio Marchetta, Enrico Fusaro, Gilda Sandri, Carlo Salvarani, Marino Paroli, Alarico Ariani

    Published 2022-02-01
    “…The main aim of this study is to compare the clinical outcomes of the treatment with adalimumab, both the originator and ABP 501, in a large cohort of patients affected by autoimmune arthritis in a real life setting. We retrospectively analysed the baseline characteristics and the retention rate in a cohort of patients who received at least a course of adalimumab (originator or ABP 501) from January 2003 to December 2020. …”
    Get full text
    Article
  17. 777

    Home-based subcutaneous immunoglobulin G replacement therapy under real-life conditions in children and adults with antibody deficiency by Hoffmann F, Grimbacher B, Thiel J, Peter HH, Belohradsky BH

    Published 2010-06-01
    “…</p> <p>Methods</p> <p>We evaluated the efficacy and safety of the SCIG Vivaglobin<sup>® </sup>(formerly known as Beriglobin<sup>® </sup>SC) under real-life conditions in a post-marketing observational study in 82 patients with primary or secondary antibody deficiencies. …”
    Get full text
    Article
  18. 778
  19. 779

    Presenting rose odor during learning, sleep and retrieval helps to improve memory consolidation: a real-life study by Jessica Knötzele, Dieter Riemann, Lukas Frase, Bernd Feige, Ludger Tebartz van Elst, Jürgen Kornmeier

    Published 2023-02-01
    “…A recent study applying a real-life paradigm indicated that additional odor cueing during a Final Test can further increase this cueing effect. …”
    Get full text
    Article
  20. 780